Month: January 2023

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — AGF Management Limited (TSX:AGF.B) reported total assets under management (AUM) and fee-earning assets1 of $40.5 billion as at December 31, 2022.AUM ($ billions) December 31,2022 November 30,2022 % ChangeMonth-Over-Month December 31,2021 % ChangeYear-Over-YearTotal Mutual Fund (including retail pooled funds) $23.1 $23.9   $24.6  Institutional and Sub-advisory + Exchange-traded funds + AGF Private Wealth $15.3 $15.8   $16.6  Subtotal (before AGF Private Capital AUM and fee-earning assets1) $38.4 $39.7   $41.2  AGF Private Capital $0.1 $0.1   $0.1  Total AUM $38.5 $39.8 (3.3 %) $41.3 (6.8 %)AGF Private Capital fee-earning assets1 $2.0 $2.0   $2.1  Total AUM and fee-earning assets1 $40.5 $41.8 (3.1 %) $43.4 (6.7 %)           Average Daily Mutual Fund AUM $23.5 $23.2   $24.4  1 Fee-earning...

Seasoned leader brings decades of legal and compliance expertise to the Board RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (Nasdaq: BLFY) (the “Company”), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately. James D. Nesci, President and Chief Executive Officer stated, “We are excited to welcome Ms. Jobes to Blue Foundry’s Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry.” Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Before joining Amryt, Jobes served as Senior Vice President and Chief...

TARRYTOWN, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 third quarter earnings release on Thursday, February 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.   To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start. A conference call replay will be available for approximately one week following completion of the live call and can be...

LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) — PacWest Bancorp (Nasdaq: PACW) (the “Company”) will report its financial results for the quarter and year-to-date period ended December 31, 2022 after the close of the stock market on Thursday, January 26, 2023. The Company will file its quarterly financial results with the SEC via Form 8-K and issue a press release via newswire, which will also be posted on the SEC Filings section of its website at http://www.pacwestbancorp.com. Management will host a conference call at 8:00 AM PT/ 11:00 AM ET on Friday, January 27, 2023 to discuss the Company’s performance. Participants may access the conference call/webcast at:Participant Dial-in: (888) 204-4368Participant Webcast Link: https://event.webcasts.com/starthere.jsp?ei=1590835&tp_key=aedee87ee7 Confirmation Code: 2205611 Please visit...

VANCOUVER, British Columbia, Jan. 05, 2023 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company“) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) announces that the Company has entered into shares for services agreements (collectively, the “Shares for Services Agreements“) with certain directors, employees, and consultants. Pursuant to the Shares for Services Agreements, such directors, employees and consultants will ‎receive all or a portion of their director fees, wages, or consultancy fees for the period from January 1, 2023 to ‎December 31, 2023 in common shares of the Company (the “Security Based Compensation“), with the remaining amount, if any, to be ‎satisfied in cash.‎ The common shares will be issued quarterly and will be subject to a four-month and one-day hold ‎period commencing...

EXPAREL average daily sales 104% of the prior year for the fourth quarter and 107% of the prior year for the month of December TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited total revenue of $666.8 million for 2022, compared with $541.5 million for 2021, representing an increase of 23.1 percent. The company’s 2022 revenue includes net product sales of EXPAREL® (bupivacaine liposome injectable suspension), ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), and the iovera°® system. Pacira began recognizing sales of ZILRETTA in November 2021 following the completion of its acquisition of Flexion Therapeutics, Inc. “Despite ongoing...

CHICAGO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop, today announced that management will participate in ICR’s 25th Annual Consumer Conference on Monday, January 9, 2023. Bob Wright, Chief Executive Officer and Steve Cirulis, Chief Financial Officer, are scheduled to present at 12:00 PM ET and hold one-on-one meetings with investors. Interested parties can access the live presentation as well as a replay on the Investor Relations section of the Company’s website at http://www.potbelly.com under the “Events and Presentations” section. About Potbelly Potbelly Corporation is a neighborhood sandwich concept that has been feeding customers’ smiles with warm, toasty sandwiches, signature salads, hand-dipped shakes and other fresh menu items,...

The Company to Reconvene the 2022 Annual Meeting on February 2, 2023 for Shareholders to Act on One Outstanding Proposal LONDON, Jan. 05, 2023 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company” or “GSL”) announced that today its 2022 Annual Meeting of Shareholders was reconvened (the “Annual Meeting”) for the sole purpose of voting on one outstanding proposal – to approve the adoption of an amendment to the Company’s Amended and Restated Articles of Incorporation establishing a quorum for all meetings of shareholders of the Company of one-third (1/3) of the shares, present either in person or by proxy, issued and outstanding and entitled to vote at such meetings (“Proposal Three”). The Annual Meeting was further adjourned without taking action on Proposal Three in order to provide additional time for shareholders...